Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Disoproxil Fumarate to Prevent Mother-to-Child Transmission of Hepatitis B
NCT03343431Phase 3Active, not recruiting
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Aug 2018
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by Institut de Recherche pour le Développement. Started Aug 2018; status: active, not recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03343431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343431.